The Bureau of Labor Statistics released the July 2026 Consumer Price Index on August 12, showing the medical care index at 1.7% year over year. That decelerated from June’s 2.0% and reads, at first glance, as a mild easing of medical inflation. The composition tells a different story: medical care services rose 2.7% over the prior 12 months while medical care commodities fell 2.7%. Drug deflation is masking sustained services inflation, and the 540-basis-point spread between the two sub-indexes is the widest in recent years. The blended headline number is the wrong trend input for a workers’ compensation reserve study.
Who it affects
Self-insured WC programs carrying open long-duration claims: public entities, hospital systems, large manufacturers, transit authorities, and single-parent captives. The exposure concentrates on catastrophic claims (traumatic brain injury, spinal cord, severe burns) where case reserves project cost over a seven-year or longer development tail. The cost mix on those claims is almost entirely services: physician visits, hospital outpatient procedures, physical therapy, and chiropractic. Prescription drug spend is a small and declining slice of WC medical costs at most programs, compressed further by state formularies and federal drug program rules.
The reserve mechanism
The lever is the medical severity trend factor embedded in the actuarial opinion. A one-percentage-point understatement, selecting 1.7% instead of 2.7%, applied to a $10 million WC medical reserve projected over a seven-year tail compounding to approximately $700,000 to $1 million in reserve shortfall. The chain-ladder will not flag a trend selection error immediately; it reads the eventual cost catch-up as adverse paid development. By then, the shortfall is already embedded in the carried reserve.
The -2.7% commodity deflation is primarily a generic drug story driven by Inflation Reduction Act pricing negotiations and ongoing patent expirations. That deflation does not apply to compound topicals, branded specialty drugs, or hospital-administered biologics. Those categories are not experiencing the commodity downturn, and they are not the dominant WC cost driver anyway. The core exposure, physician and facility services, is inflating at 2.7%.
The ASOP 43 angle
This is where the July data produces a new obligation, not just a methodological note. Actuarial Standard of Practice No. 43, Section 3.4, requires that trend assumptions reflect expected future changes in costs. An actuary using the 1.7% blended CPI as the trend input without adjustment is embedding a systematic downward bias created by a cost category that represents a minor and shrinking share of WC medical spend.
ASOP 43’s disclosure requirements are triggered when a known, material limitation is present in an assumption. The divergence between the services and commodities sub-indexes is now a documented, sustained pattern, confirmed across consecutive monthly CPI releases. June showed the same split at 2.9% services versus -2.1% commodities. An opinion that uses 1.7% without comment is not consistent with ASOP 43’s disclosure standard if the services-commodities composition was knowable at valuation date. It was.
A self-insured buyer reviewing the actuarial opinion should find either an adjustment to a services-only or WC-specific trend index, or explicit language quantifying the impact of including drug commodity deflation in the blended trend selection. The ask is reasonable and grounded in the standard.
Fee-schedule amplification
Fee-schedule states partially buffer the services inflation: states tying WC physician and hospital outpatient payments to Medicare rates cap cost growth at the pace of schedule updates. The exposure concentrates in states without physician or facility fee schedules. WCRI’s 2026 Medical Price Index found WC physician prices up to 188% higher than the fee-schedule median in no-schedule states. WCRI’s hospital outpatient index put Alabama WC outpatient surgery payments at 471% of Medicare, with no regulatory ceiling on growth. For programs with concentration in those states, 2.7% is a floor on services trend, not a ceiling. The 2026 Medicare physician conversion factor increase adds another layer: fee-schedule states pegged to Medicare absorbed a 3.3% physician rate increase effective January 2026, which is itself above the 1.7% headline.
What this means for your next review
At your next reserve study, ask your actuary three questions: Is the medical trend assumption based on the BLS blended headline, the services-only sub-index, or a WC-specific index calibrated to your state mix? Does the opinion disclose that services and commodities components are diverging and quantify the effect on trend selection? If the blended index was used, does the sensitivity section show the reserve implication of moving to a services-only assumption? These questions follow directly from ASOP 43, and an independent second opinion should be on the agenda if the answers are unsatisfying. The WC IBNR explainer covers the development methodology context behind the trend factor’s role in the reserve calculation.
Sources
- BLS Consumer Price Index Summary, July 2026 (released August 12, 2026)
- WCRI Medical Price Index for Workers’ Compensation, 17th Edition
- WCRI Hospital Outpatient Payment Index for Workers’ Compensation, 2026
- NCCI: Medicare Fee Schedules and Workers Compensation in 2026
- Actuarial Standards Board, ASOP No. 43: Property/Casualty Unpaid Claim Estimates